Ki Summary

Reaction Details

Report a problem with these data

Target

Gastrin/cholecystokinin type B receptor

Ligand

BDBM50045799

Substrate/Competitor

n/a

Meas. Tech.

ChEBML_49880

407±n/a nM

Citation

Blommaert, AG; Weng, JH; Dorville, A; McCort, I; Ducos, B; Durieux, C; Roques, BP Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. J Med Chem36:2868-77 (1993) [PubMed]

More Info.:

Get all data from this article, Assay Method

Gastrin/cholecystokinin type B receptor

Name:

Gastrin/cholecystokinin type B receptor

Synonyms:

Type:

G Protein-Coupled Receptor (GPCR)

Mol. Mass.:

48445.79

Organism:

Homo sapiens (Human)

Description:

Stable expression of human CCK-2 receptors in HEK 293 cells.

Residue:

447

Sequence:

MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITL
YAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF
IFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWL
LSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGL
ISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRS
RPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDG
PGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRAL
PDEDPPTPSIASLSRLSYTTISTLGPG

BDBM50045799

n/a

Name

BDBM50045799

Synonyms:

CHEMBL318238 | [2-(1H-Indol-3-yl)-1-methyl-1-phenylcarbamoyl-ethyl]-carbamic acid adamantan-2-yl ester

Type

Small organic molecule

Emp. Form.

C29H33N3O3

Mol. Mass.

471.5906

SMILES

CC(Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)Nc1ccccc1 |wU:23.24,wD:21.23,19.27,17.19,TLB:15:16:18:21.25.20,THB:22:23:18:21.25.20,22:21:18:16.23.24,(14.71,-10.97,;13.38,-11.76,;12.05,-12.53,;12.06,-14.08,;12.97,-15.31,;12.07,-16.57,;10.6,-16.11,;9.25,-16.88,;7.92,-16.11,;7.92,-14.56,;9.25,-13.79,;10.59,-14.56,;11.88,-11.35,;10.55,-10.58,;9.45,-11.67,;10.15,-9.08,;8.66,-8.69,;7.33,-7.89,;6.77,-6.49,;5.13,-6.63,;4.02,-7.68,;4.56,-9.08,;5.84,-9.74,;6.91,-8.7,;6.35,-7.4,;6.18,-8.99,;14.71,-12.51,;14.71,-14.05,;16.25,-12.51,;17.02,-11.18,;16.25,-9.85,;17.01,-8.52,;18.56,-8.52,;19.33,-9.85,;18.56,-11.18,)|

Structure